Generic Drug Industry in South Korea: Market Research Reports, Statistics and Analysis

Company Report: Generic Drug In South Korea For Year 2013

... Accounted for 15.1% Of the generic drug market (as of 4q12), followed by cj (13.5%), Hanmi (4.7%), Shinpoong (4.0%), And ilong (3.2%). Recommend yuhan as top pick; ckd maintained as second-preferred stock ...

Company Report: Generic Drug In India, The United States And Sout ...

... For any newly innovated medicine. While the move is expected to have a financial impact on generic drug makers in a positive way as it will improves the speed of approval. The proposed generic user fee ...

The South Korean Generic Drug Industry : Innovation And Technolog ...

... Costs ega improving competitiveness increasing market share promoting sustainable pricing quicker access to the market (stm) challenges for the european generic medicines market inquiry identifies ...

Company Report: Generic Drug In Japan, South Korea And Switzerlan ...

... To contend with a signifi- cant increase in expenditure on healthcare. Compared with other developed countries there is only a very low generic drug penetra- tion in japan. In 2004, the generics share ...

Company Report: Generic Drug In Japan, South Korea And Switzerlan ...

... Older, japan has to contend with a significant increase in expenditure on healthcare. Compared with other developed countries there is only a very low generic drug penetration in japan. In 2004 ...

Biogen Idec - Investment Analysis, April 2012

Company Report: Generic Drug In Asia For Year 2012

Company Report: Generic Drug In Japan, South Korea And Switzerlan ...

... To contend with a signifi- cant increase in expenditure on healthcare. Compared with other developed countries there is only a very low generic drug penetra- tion in japan. In 2004, the generics share ...

Company Report: Generic Drug In India, Greece And South Korea For ...